Open AccessManagement of High Disease Activity in Multiple Sclerosis Using ZytuxTM (Rituximab, AryoGen Pharmed): Evidence from a Case Report
Author(s) -
Abdorreza Naser Moghadasi,
Esmaeil Ghoreyshi Tayyebi
Publication year - 2020
Publication title -
journal of kermanshah university of medical sciences
Language(s) - English
Resource type - Journals
eISSN - 2588-2570
pISSN - 2588-2562
DOI - 10.5812/jkums.101422
Subject(s) - rituximab , medicine , fulminant , multiple sclerosis , methylprednisolone , cd20 , disease , pediatrics , immunology , lymphoma
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom